Skip to content

TXG

10x Genomics, Inc.

Stock

$93.50+4.74 (+5.34%)Close Oct 2, 2026

EBITDA, 2025
−$25M

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025−$25M—
2024−$159M—
2023−$230M—
2022−$143M—
2021−$31M—
2020−$520M—
2019−$24M—
2018−$107M—
2017−$14M—